Millennium Management
BCAX

Millennium Management’s Bicara Therapeutics BCAX Stock Holding History

Millennium Management’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.79M Buy
262,254
+105,552
+67% +$2.36M ﹤0.01% 2562
2026
Q1 		$3.12M Sell
156,702
-277,997
-64% -$4.79M ﹤0.01% 3434
2025
Q4 		$7.32M Sell
434,699
-580,193
-57% -$9.91M ﹤0.01% 2595
2025
Q3 		$16M Buy
1,014,892
+273,873
+37% +$3.07M 0.01% 1917
2025
Q2 		$6.88M Buy
741,019
+715,371
+2,789% +$8.53M ﹤0.01% 2642
2025
Q1 		$334K Sell
25,648
-359,758
-93% -$4.78M ﹤0.01% 5040
2024
Q4 		$6.71M Buy
385,406
+85,847
+29% +$1.79M ﹤0.01% 2551
2024
Q3 		$7.63M Buy
+299,559
New +$7.64M ﹤0.01% 2445

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management's BCAX Position: Q2 2026 in Review

Millennium Management increased its Bicara Therapeutics (BCAX) stake by 67% in Q2 2026, buying an estimated $2.36M and bringing the position to 262,254 shares worth $7.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Millennium Management first reported a position in BCAX in Q3 2024 and has held it in 8 quarters since. The position peaked at $16M in Q3 2025. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Millennium Management held 262,254 shares of Bicara Therapeutics worth $7.79M as of Q2 2026.
  • Millennium Management bought 105,552 Bicara Therapeutics shares in Q2 2026, an estimated $2.36M.
  • Bicara Therapeutics made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #2562 holding.
  • Millennium Management first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Millennium Management's Bicara Therapeutics position peaked at $16M in Q3 2025.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.